Ghrelin and ghrelin receptor inhibitors: agents in the treatment of obesity

Author： Soares João-Bruno Roncon-Albuquerque Roberto Leite-Moreira Adelino

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.9, 2008-09, pp. : 1177-1189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methods for synthesis and uses of inhibitors of Ghrelin O-acyltransferase inhibitors as potential therapeutic agents for obesity and diabetes

By Costantino Luca

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 11, 2010-11 ,pp. : 1603-1607

Informa Healthcare

Access to resources Recommend Favorite

Immunization Against Active Ghrelin Using Virus-Like Particles for Obesity Treatment

Current Pharmaceutical Design, Vol. 19, Iss. 36, 2013-01 ,pp. : 6551-6558

Bentham Science Publishers

Access to resources Recommend Favorite

The Use of Ghrelin and Ghrelin Receptor Agonists as a Treatment for Animal Models of Disease: Efficacy and Mechanism

Current Pharmaceutical Design, Vol. 18, Iss. 31, 2012-10 ,pp. : 4779-4799

Bentham Science Publishers

Access to resources Recommend Favorite

Ghrelin in Obesity, Physiological and Pharmacological Considerations

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 4, 2013-04 ,pp. : 541-552

Bentham Science Publishers

Access to resources Recommend Favorite

Ghrelin as a Potential Anti-Obesity Target

Current Pharmaceutical Design, Vol. 9, Iss. 17, 2003-07 ,pp. : 1383-1395

Bentham Science Publishers

Access to resources Recommend Favorite